Question
Enumerate SERMs. Write in detail about any one member.
(2+4)
Answer
SERMs: Tamoxifen, Raloxifene, Clomiphene.
One member in detail — Tamoxifen A selective estrogen receptor modulator, acting as an estrogen antagonist in breast tissue while behaving as a partial agonist in the endometrium and bone. Mechanism: competitively binds estrogen receptors, blocking estrogen-driven proliferative signaling specifically in breast tissue. Uses: ER-positive breast cancer (adjuvant and metastatic therapy), chemoprevention in high-risk women. Adverse effects: hot flushes, increased risk of endometrial hyperplasia/cancer (from its partial agonist action on the endometrium), venous thromboembolism, and an increased risk of cataracts with long-term use. Its bone-agonist action incidentally helps preserve bone mineral density, an added benefit distinct from its anti-tumour action.
Related Concepts
Other Years Asked
- 1What are the different types of oral contraceptive pills available. Describe the mechanism of action and adverse effects of combined oral contraceptive pills.(2+2+2)2021 December (Supplementary) (2010 Scheme)Essay · 6 marks
- 2Classify uterine stimulants and relaxants with suitable examples. Explain the rationale for the use of oxytocin in prevention of postpartum haemorrhage (PPH).(4+2)2025 March (Supplementary (SAY)) (2019 Scheme)Short Essay · 6 marks
- 3A recently married woman comes to your clinic with complaints of calf tenderness. She says she has been using a tablet for preventing pregnancy.(a)Classify hormonal contraceptives(b)Enumerate the advantages, disadvantages and precautions while using these drugs2020 February (Supplementary) (2010 Scheme)Essay · 4 marks
- 4((a)Briefly describe Mifepristone ((b)Uses of Anabolic steroids2023 January (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 5Uses of Selective Estrogen Receptor Modulators2022 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 6Pharmacological basis for the use of Tamoxifen in Carcinoma Breast.2023 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 7Classify the Selective Estrogen Receptor Modulators (SERMs) and explain the pharmacological basis of their clinical indications.2024 March (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 8Mention two anabolic steroids. Enumerate the uses and adverse effects of anabolic steroids.2024 December (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 9Briefly describe combined Oral Contraceptive Pills. Add a note on emergency contraception.(3+1)2022 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 10Serious adverse effects produced by oral contraceptive pills2014 March (2010 Scheme)Short Note · 3 marks
- 11Raloxifene2018 February (2010 Scheme)Short Note · 3 marks
- 12Post coital contraceptives2016 October (Supplementary) (2010 Scheme)Short Note · 3 marks
- 13Mifepristone2013 April (2010 Scheme)Short Note · 3 marks
- 14Clomiphene citrate.2015 September (Supplementary) (2010 Scheme)Short Note · 3 marks
- 15Clomiphene citrate.2025 March (Supplementary) (2010 Scheme)Short Note · 3 marks
- 16Clomiphene citrate2017 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 17Mifepristone in termination of pregnancy2022 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 18Raloxifene2019 February (2010 Scheme)Short Answer · 1 mark
- 19Letrozole in early breast cancer2019 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 20Selective estrogen receptor modulators2015 February (2010 Scheme)Short Answer · 1 mark
- 21Letrozole in breast cancer after surgery2021 May (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 22Tocolytics2014 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 23Selective estrogen receptor modulators2014 March (2010 Scheme)Short Answer · 1 mark
- 24Assertion (A): Sildenafil is used in male sexual dysfunction.Reason (R): Sildenafil is a phosphodiesterase inhibitor causes accumulation of cGMP and marked potentiation of actions of nitric oxide.2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 25Uterine relaxants2018 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 26Rationale of estrogen in hormone replacement therapy2014 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 27Treatment of Female Infertility.2017 February (2010 Scheme)Short Answer · 1 mark
- 28Clomiphene citrate.2024 March (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 29Uterine relaxants2013 April (2010 Scheme)Short Answer · 1 mark
- 30Two uses and two adverse effects of oral contraceptive pills2014 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 31Uterine stimulants2013 April (2010 Scheme)Short Answer · 1 mark
- 32Uterine stimulants2016 February (2010 Scheme)Short Answer · 1 mark
- 33Centchroman2016 February (2010 Scheme)Short Answer · 1 mark
- 34Ovulation inhibitors2018 February (2010 Scheme)Short Answer · 1 mark
- 35Combination of Oestrogen and Progesterone in Oral contraceptive pills2025 March (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 36Anabolic steroids2017 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 37Raloxifene is used in the treatment of Osteoporosis in postmenopausal women2025 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 38Rationale for the combination of oestrogen and progesterone in OCPs.2013 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 39Selective Estrogen Receptor Modulators.2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 40Selective Estrogen Receptor Modulators (SERM)2024 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 41Topical steroids2021 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 42Combined pill/Mini pill as oral contraceptionName the following (Two examples for each) (5x1=5)2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 43Selective estrogen receptor modulators2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 44Antiestrogens2021 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 45Anabolic steroids2022 October (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 46Anti-progestins2022 February (2019 Scheme)Short Answer · 0.2 marks
- 47Anabolic steroids.2022 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 48Antioestrogens.2023 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 49Drugs for Emergency contraception2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 50Anabolic steroids2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks

